-
Amaryllis
The amaryllis is a symbol of strength and determination for the HD community. Place your orders starting October 18th!
-
2023 HDSA Annual Report
We’re thrilled to announce the release of the 2023 HDSA Annual Report, highlighting the amazing progress we've achieved as One HDSA.
-
JOIN POWER HD
By generating the most comprehensive patient-driven Huntington’s disease data we can accelerate research and the development of new drugs, devices, or other therapies. YOU HAVE THE POWER.
-
HD SYMPTOMS AND TREATMENT IMPACT SURVEY
This first-of-its kind survey has been created by the HD community for the HD community. When you take this survey, you will be informing the FDA, NIH and medical product developers how you describe the challenges of living with HD, manage symptoms, and define the value of new treatments.
-
SAVE THE DATE!
Join us for the 40th Annual HDSA Convention in Indianapolis, Indiana on June 26-28, 2025 This is your unique chance to connect, learn, inspire and get inspired. Our convention is not just an event – it’s a celebration, it’s magic!
-
HDSA Publishes 2023 Year In Review Magazine
Take a look back on HDSA's achievements and top stories from 2023 in the latest Year In Review Magazine.
-
Annual HDSA Convention Registration is Now Open!
Join us for the 39th Annual HDSA Convention in Spokane, Washington, May 30- June 1, 2024
-
THE MARKER: 2023 HDSA RESEARCH REPORT
In 2023, HDSA supported fantastic Huntington’s disease science, shared research news with the community, and amplified family voices in drug development. The latest issue of The Marker is now available!
-
FIND HDSA RESOURCES NEAR YOU
HDSA provides world-class support programs and resources across the country for everyone impacted by Huntington’s disease. Visit our interactive map to get started today!
-
#LetsTalkAboutHD with Ginger Hermes
-
HDSA SOCIAL WORKERS
HDSA Social Workers are often the first voice that someone new to HD may hear. Social workers offer information, education and access to community based services within a specific region.
-
HDSA SUPPORT GROUPS
HDSA support groups are free for individuals, their loved ones, and families impacted by Huntington’s disease.
-
Research Trial Now Recruiting at Venderbilt
The Roche/Genentech GENERATION HD2 Trial is testing a drug called tominersen for its safety and ability to lower harmful huntingtin protein. This study is recruiting at the HDSA Center of Excellence at Vanderbilt University in Nashville. You can also view this trial on HD Trialfinder for more information. Create an HD Trialfinder profile or re-match today to find more opportunities to participate near you.